Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 9.9M | 10.4M | 11.6M | 11.9M |
Selling general and admin | 2.6M | 3.1M | 2.8M | 2.9M |
Other operating expenses | -96K | -12K | — | — |
Operating income | -12.4M | -13.6M | -14.3M | -14.7M |
Non operating interest income | ||||
Income | 1.2M | 1.4M | 1.8M | 1.8M |
Expense | — | — | 0 | 0 |
Other income expense | 11K | 75K | 758K | 652K |
Pretax income | -11.2M | -12.1M | -11.7M | -12.3M |
Tax provision | — | — | -124K | -67K |
Net income | -11.2M | -12.1M | -11.6M | -12.2M |
Basic EPS | -0.1 | -0.1 | — | -0.1 |
Diluted EPS | -0.1 | -0.1 | — | -0.1 |
Basic average shares | 85.1M | 84.8M | — | 84.5M |
Diluted average shares | 85.1M | 84.8M | — | 84.5M |
EBITDA | -12.4M | -13.2M | -11.9M | -12.3M |
Net income from continuing op. | -11.2M | -12.1M | -11.6M | -12.2M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |